RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kevin Bennett to Nanoparticles

This is a "connection" page, showing publications Kevin Bennett has written about Nanoparticles.
Connection Strength

1.376
  1. Charlton JR, Pearl VM, Denotti AR, Lee JB, Swaminathan S, Scindia YM, Charlton NP, Baldelomar EJ, Beeman SC, Bennett KM. Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents. Nanomedicine. 2016 08; 12(6):1735-45.
    View in: PubMed
    Score: 0.396
  2. Bennett KM, Jo J, Cabral H, Bakalova R, Aoki I. MR imaging techniques for nano-pathophysiology and theranostics. Adv Drug Deliv Rev. 2014 Jul; 74:75-94.
    View in: PubMed
    Score: 0.346
  3. Charlton JR, Beeman SC, Bennett KM. MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease. Adv Chronic Kidney Dis. 2013 Nov; 20(6):479-87.
    View in: PubMed
    Score: 0.334
  4. Bennett KM, Zhou H, Sumner JP, Dodd SJ, Bouraoud N, Doi K, Star RA, Koretsky AP. MRI of the basement membrane using charged nanoparticles as contrast agents. Magn Reson Med. 2008 Sep; 60(3):564-74.
    View in: PubMed
    Score: 0.234
  5. Colomb J, Louie K, Massia SP, Bennett KM. Self-degrading, MRI-detectable hydrogel sensors with picomolar target sensitivity. Magn Reson Med. 2010 Dec; 64(6):1792-9.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support